Beranda › Limfoma Sel B Besar Difus › North Carolina › Greenville
Uji klinis Limfoma Sel B Besar Difus di Greenville, NC
4 studi untuk Limfoma Sel B Besar Difus mencari peserta di lokasi sekitar Greenville (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Menerima pesertaFase 3
- East Carolina University ( Site 0159), Greenville
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Menerima pesertaFase 3
- East Carolina University, Greenville
Registry of Older Patients With Cancer
Menerima pesertaStudi observasional
- East Carolina University, Greenville
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Menerima pesertaFase 2
- Brody School of Medicine at East Carolina University, Greenville
Uji klinis Limfoma Sel B Besar Difus di kota lain
- New York City, NY21 studi
- Baldwin Park, CA19 studi
- Chicago, IL18 studi
- Houston, TX17 studi
- Los Angeles, CA17 studi
- Boston, MA16 studi
- Milwaukee, WI16 studi
- Nashville, TN15 studi
- Portland, OR15 studi
- Philadelphia, PA15 studi
- Durham, NC14 studi
- Dallas, TX13 studi
Studi lain di Greenville
- Leukemia Mieloid Akut10 studi
- Penyakit Sel Sabit9 studi
- Gagal Jantung6 studi
- Purpura Trombositopenik Idiopatik6 studi
- Gangguan Darah5 studi
- Leukemia Limfositik Kronis5 studi
- Limfoma Burkitt5 studi
- Obesitas5 studi
- Diabetes Tipe 25 studi
- Penyakit Autoimun4 studi
- Tekanan Darah Tinggi4 studi
- Neoplasma Mieloproliferatif4 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.